ARTICLE | Company News
Eisai sets Belviq price
February 26, 2013 1:32 AM UTC
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) disclosed in an SEC filing that partner Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) set a wholesale acquisition cost (WAC) of $199.50 for a one-month supply of twi...